1086 Evaluating a New Sleep Testing Device for Pediatric Patients: A Comparative Analysis of Type 2 HST vs In-lab PSG
Abstract
High-quality sleep is critical for children’s and adolescents’ development and health. Despite the high prevalence of sleep disorders in this population, few polysomnography devices have tested specifically for pediatric use. We evaluated the Dormotech device, a novel sleep monitoring system designed for both clinical and home-based sleep studies, against gold standard polysomnographic equipment.
Twenty-six children (mean age = 11.0 years, 50% female, mean body mass index 26.0 kg/m2) underwent simultaneous sleep studies with the novel device and gold-standard polysomnography in a sleep clinic. Data were manually scored following recommended guidelines. The primary outcome was apnea-hypopnea index (AHI) and its corresponding severity classification level (i.e. normal, mild, moderate, severe). Secondary endpoints included other standard polysomnography (PSG) parameters.
The mean AHI measured by the novel device was 5.6 ± 15.3 events/h (mean ± standard deviation) while it was 5.2 ± 13.8 events/h from the gold standard PSG (p = 0.95, t-test). AHI severity classification showed excellent inter-test agreement (Cohen’s kappa = 0.87). Secondary endpoints demonstrated high correlation between devices, with no statistically significant differences in simultaneously recorded sleep measurements. No adverse safety events were reported.
The novel device provides sleep study data comparable to conventional polysomnography in pediatric patients, offering clinically identical test…
Read the paper
Related studies
- Tryptophan Metabolism and Gut-Brain Homeostasis
- Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
- Prioritized Research for the Prevention, Treatment, and Reversal of Chronic Disease: Recommendations From the Lifestyle Medicine Research Summit
- Relationship between sleep disorders and gut dysbiosis: what affects what?
- The role of CLOCK gene in psychiatric disorders: Evidence from human and animal research
- Genetic, Transcriptome, Proteomic, and Epidemiological Evidence for Blood-Brain Barrier Disruption and Polymicrobial Brain Invasion as Determinant Factors in Alzheimer’s Disease
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.